GSK new HIV two-drug injection meets main goal in late-stage study
August 22, 2019 at 02:40 AM EDT
British drugmaker GlaxoSmithKline Plc said on Thursday its long-lasting two-drug regimen to treat HIV met the main goal of a late-stage study.
